Introducing iLite® IFN FAST second-generation assay-ready cells Effective bioassays are crucial in pharmaceutical development for assessing potency and detecting neutralizing antibodies in immunogenicity studies. Our iLite IFN FAST second-generation cells offer shorter incubation times, Renilla ... Read more
Testing of GFAP in serum can provide valuable information in both traumatic brain injury and stroke. It is also helpful for certain neurodegenerative and neuroinflammatory conditions. We are now expanding our offering for GFAP by providing testing in serum. Additionally, serum and cerebrospinal ... Read more
Therapeutic antibodies have revolutionized biopharmaceutical drug development, offering targeted treatments for a range of diseases, from autoimmune disorders to oncology. However, immunogenicity remains a critical hurdle, as the formation of anti-drug antibodies (ADAs) can impact drug efficacy, ... Read more
Therapeutic antibodies have transformed modern biopharmaceuticals, providing targeted and highly specific treatments for a range of diseases, including oncology, autoimmune disorders, and infectious diseases. However, immunogenicity concerns, particularly the development of anti-drug antibodies ... Read more
